Page results
-
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
-
Johanna Moss was appointed to the Board on 7 January 2025 as the director of strategy. Prior to this Jo was the chief strategy and transformation officer for the North East London Integrated Care Board and she also held the role of director of strategy and partnerships at Moorfields Eye Hospital NHS Foundation Trust for seven years, where she was the lead for their major capital project to build a new hospital and research centre in Camden.
-
Medtronic have informed us that there is a potential issue relating to the battery cap on some Medtronic insulin pumps (including 640, 670 and 780 series pumps).
-
Patient story - Zehavah Handler - When sleep becomes a nightmare. Zehavah Handler struggled to sleep for 25 years before completing a five-week course at UCLH’s insomnia clinic. Here, she tells us how it changed her life.
-
There’s a lot of information available out there. Here you can find information about type 1 and type 2 diabetes.
-
An online exhibition by Dr Sarah Yardley and artist Daniel Regan, exploring the role of relationships and relationship-centred approaches to healthcare.
-
This week, clinical leaders across north central London have written to our local newspapers, outlining the rationale for temporary changes to children and young people's services across the region. The letter reflects on some of the lessons learnt from the first wave of the COVID-19 pandemic and the need to plan ahead for a likely second surge and a busy winter with all of the challenges that will bring. You can read the letter in full here:
-
UCLH cancer services including radiotherapy has been awarded the PIF TICK – the UK’s only assessed quality mark for print and online health and care information.
-
Prime Minister, Sir Keir Starmer, was joined by Health and Social Care Secretary, Wes Streeting, for a tour of the University College Hospital Grafton Way Building where they met staff and patients.
-
UCLH will transition to a new Laboratory Information Management System (LIMS) for Blood Science disciplines’ (Biochemistry, Immunology, Haematology, Coagulation and Virology) testing. The new platform is known as ‘Helix’. This is a change to the laboratory system only, as such there should be no change to GP users in requesting or receiving reports.
File results
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis